Why Governments Pay Two Different Prices for the Same Drug

Episode 28 of The Fiscal Policy Podcast uncovers a strange asymmetry in US government spending: the Department of Veterans Affairs pays dramatically less for prescription drugs than Medicare Part D does — sometimes two to three times less for the exact same medication. Hosts Lucas and Luna trace the root cause to a 1992 law that explicitly banned Medicare from negotiating prices, a restriction that doesn't apply to the VA. They walk through the 2022 Inflation Reduction Act's attempt to close the gap, the legal challenges from pharmaceutical companies, and why the Congressional Budget Office scored the negotiation provision as saving $98 billion over a decade. The episode also explores how this pricing puzzle reflects deeper tensions in federal fiscal policy: one agency paying market forces, another paying a near-monopsony price, and the taxpayer caught in between. A focused look at how a single legal carve-out distorts billions in public spending. #FiscalPolicy #GovernmentSpending #Medicare #VeteransAffairs #DrugPricing #InflationReductionAct #PrescriptionDrugs #CongressionalBudgetOffice #Monopsony #PharmaceuticalIndustry #PriceNegotiation #PartD #VA #FederalBudget #TaxpayerCost #HealthcareEconomics #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo